Novalar Pharmaceuticals has entered into an exclusive license and distribution agreement with Sanofi-Aventis Deutschland to offer its vasodilator drug phentolamine mesylate, OraVerse, in Germany beginning
DentalVibe, a new dental device that its developers claim takes the fear and pain out of dental injections, was introduced last week at the Chicago
The U.S. FDA has asked Novalar Pharmaceuticals to stop distributing a patient brochure for the drug OraVerse (phentolamine mesylate), which it markets for reversing the
Milestone Scientific expects to report a $2 million year-over-year increase in revenues for the most recent fiscal year (end-December 31), despite some shipping delays and
Q: What are your thoughts on the STA machine? Does it really make injections easier? A: The STA from Milestone Scientific stands for single tooth
A New York family is suing St. Luke’s Hospital in Manhattan and its chief dentist, Bruce Lish, D.D.S., after a 33-year-old woman with cerebral palsy
Promising to “bring an end to traumatic dental visits,” Medical International Technology (MIT) plans to launch a version of its Med-Jet needleless injector for the
NEW YORK (Reuters), Jan 29 – A Manhattan federal judge refused on Friday to dismiss a lawsuit alleging that Merck & Co. Inc.’s osteoporosis drug
NEW YORK (Reuters Health), Jan 26 – Rituximab can improve saliva secretion and other parameters in patients with primary Sjögren’s syndrome, researchers report. Rituximab binds
Illinois has become the first state in the U.S. to enact a law requiring all dental offices in Illinois to have a written medical emergency
Levin Group announced that it has been engaged by Novalar Pharmaceuticals to develop a program to demonstrate to dental professionals the value of OraVerse as
The U.S. market for anesthesia, respiratory and sleep management devices will reach $4.1 billion by 2015, according to a new report series by iData Research.
